ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,331Medicare Part D Prescriptions Filled, Including Refills
$716K Total Retail Price of All Prescriptions
487 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
NAMENDA 961 949
DONEPEZIL HCL 724 706
LEVOTHYROXINE SODIUM 514 488
OMEPRAZOLE 406 383
HYDROCODONE-ACETAMINOPHEN 332 316 S3
SERTRALINE HCL 325 325
WARFARIN SODIUM 321 314
LISINOPRIL 291 290
METOPROLOL TARTRATE 291 290
FUROSEMIDE 272 258
QUETIAPINE FUMARATE 246 246
SIMVASTATIN 233 232
RISPERIDONE 228 223
MIRTAZAPINE 213 212
CITALOPRAM HBR 205 189
AMLODIPINE BESYLATE 172 166
TRAZODONE HCL 155 155
ATENOLOL 153 153
CARVEDILOL 153 144
GABAPENTIN 150 150
METOPROLOL SUCCINATE 133 130
GALANTAMINE HBR 132 123
ALENDRONATE SODIUM 129 128
SEROQUEL 120 120
PREDNISONE 104 96
POTASSIUM CHLORIDE 101 101
POLYETHYLENE GLYCOL 3350 99 98
ESCITALOPRAM OXALATE 89 89
TAMSULOSIN HCL 87 87
CARBIDOPA-LEVODOPA 86 73
KLOR-CON M10 84 84
LEVETIRACETAM 82 70
CLOPIDOGREL 76 73
SPIRIVA 73 59
HYDROCHLOROTHIAZIDE 73 72
ENALAPRIL MALEATE 70 70
NEXIUM 69 56
CEPHALEXIN 67 67
NYSTATIN 66 66
DIVALPROEX SODIUM 66 66
LIDODERM 65 65
KLOR-CON M20 65 51
ADVAIR DISKUS 64 62
LOPERAMIDE 60 59
TIMOLOL MALEATE 56 56
ATORVASTATIN CALCIUM 56 56
AGGRENOX 55 55
EXELON 55 55
OXYCODONE HCL 54 53 S2
ALBUTEROL SULFATE 52 49
TRIAMTERENE-HCTZ 52 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.